GB Patent

GB201113538D0 — Novel estrogen receptor ligands

Assigned to Karo Healthcare AB · Expires 2011-09-21 · 15y expired

What this patent protects

Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R1 to R9 have meanings as defined in the Specification, are useful as estrogen receptor ligands.

USPTO Abstract

Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R1 to R9 have meanings as defined in the Specification, are useful as estrogen receptor ligands.

Drugs covered by this patent

Patent Metadata

Patent number
GB201113538D0
Jurisdiction
GB
Classification
—
Expires
2011-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Karo Healthcare AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.